Resolution criteria
This market resolves to YES if, prior to January 1, 2050 (11:59 PM UTC), the United States experiences and responds to a new infectious disease pandemic distinct from COVID-19.
Specifically, this requires at least one of the following official determinations:
The World Health Organization (WHO) explicitly characterizes a new pathogen outbreak as a "pandemic" (or invokes equivalent terminology under international health regulations for a global pandemic), and the United States reports widespread domestic community transmission.
The President of the United States or the Secretary of the U.S. Department of Health and Human Services (HHS) declares a nationwide Public Health Emergency (or National Emergency) explicitly in response to a novel pandemic pathogen, accompanied by federal pandemic mitigation or response operations (e.g., mass vaccination campaigns, nationwide travel/quarantine advisories, or deployment of the Strategic National Stockpile).
Edge cases:
Resurgences, variants, or waves of SARS-CoV-2 (COVID-19) do not qualify; the infectious agent must be a novel or distinct pathogen (e.g., a novel influenza strain, Disease X).
Seasonal epidemics (such as recurring seasonal influenza or endemic RSV) do not qualify unless formally designated as a novel pandemic.
Declared Public Health Emergencies of International Concern (PHEICs) that do not result in significant domestic transmission or nationwide response measures within the United States (such as localized international containment efforts) do not qualify.
If no such pandemic event and U.S. response occur before January 1, 2050, the market resolves to NO.
Background
Epidemiological modeling and historical precedents indicate that major pandemics occur periodically, driven by zoonotic spillovers, urbanization, global travel, and environmental shifts. Notable global pandemics affecting the U.S. over the past century include the 1918 H1N1 influenza pandemic, the 1957–1958 H2N2 pandemic, the 1968 H3N2 pandemic, the 2009 H1N1 swine flu pandemic, and the COVID-19 pandemic declared in March 2020.
Global public health bodies monitor priority pathogens with pandemic potential, including high-pathogenicity avian influenza (such as H5N1), filoviruses, coronaviruses, and hypothetical novel agents broadly termed "Disease X."